Oculus Innovative Sciences

Oculus to create subsidiary for anti-infective drug assets
Mon, 11/26/12 - 09:46 pm
Oculus Innovative Sciences
Oculus Innovative Sciences Completes Patient Enrollment in Study of Microcyn(R) Hydrogel in Management of Scars
Wed, 11/14/12 - 10:50 pm
Oculus Innovative Sciences
patient
Microcyn
Oculus Innovative Sciences Announces Publication of Results From Study of Microcyn(R) Technology-Based Antipruritic Hydrogel in Treatment of Atopic Dermatitis
Thu, 09/27/12 - 10:36 pm
Oculus Innovative Sciences
research
Microcyn
treatment
dermatitis
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Prevention and Treatment of Peritonitis With Microcyn(R) Technology
Tue, 09/11/12 - 10:39 pm
Oculus Innovative Sciences
US
patent
treatment
Microcyn
Oculus receives $5.1M licensing fee from More Pharma
Thu, 09/6/12 - 08:17 pm
Oculus Innovative Sciences
licensing
Oculus Begins Enrolment for Microcyn
Tue, 08/21/12 - 09:00 pm
Oculus Innovative Sciences
Microcyn
clinical trials
Oculus Innovative Sciences' CEO Discusses F1Q13 Results - Earnings Call Transcript
Mon, 08/6/12 - 12:07 pm
Oculus Innovative Sciences
CEO
earnings
China Biotech In Review: Deals, Trials And Regulations
Seeking Alpha
Sun, 07/15/12 - 11:36 am
Ascletis
Walvax Biotech
Fengmao Biotech
Siegfried Holding
Oculus Innovative Sciences
Oculus Innovative Sciences Receives Chinese SFDA Regulatory Approval of Microcyn(R) Hydrogel
Tue, 07/10/12 - 10:29 pm
Oculus Innovative Sciences
China
Microcyn
regulatory
AmDerma and Oculus Innovative Sciences Enter Into Multi-Country Agreement to Develop and Commercialize Novel Microcyn(R)-Based Drugs for Major Dermatological Conditions
Mon, 06/25/12 - 11:14 pm
AmDerma
Oculus Innovative Sciences
contract
dermatology
Oculus Innovative Sciences Reports Fiscal Fourth Quarter 2012 Financial Results
Fri, 06/8/12 - 12:54 pm
Oculus Innovative Sciences
earnings
Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2012 Financial Results and Conference Call
Thu, 05/24/12 - 09:17 pm
Oculus Innovative Sciences
earnings
Oculus Innovative Sciences, Inc. to Raise $3.1 Million in Registered Direct Offering
Mon, 04/23/12 - 10:41 pm
Oculus Innovative Sciences
stock
$10 Billion Market Opportunity For Oculus
Seeking Alpha
Fri, 02/10/12 - 10:47 am
Oculus Innovative Sciences
Microcyn
antibiotics
antibiotic resistance
Oculus Innovative Sciences Reports Fiscal Third Quarter 2012 Financial Results
Thu, 02/2/12 - 09:14 pm
Oculus Innovative Sciences
earnings
Oculus Innovative Sciences, Inc. to Raise Approximately $2.0 Million in Registered Direct Offering
Fri, 12/23/11 - 05:22 pm
Oculus Innovative Sciences
funding
Global Situation & Resulting Influences - Research Report on Oculus Innovative Sciences, Inc. and Allergan, Inc.
Sat, 09/24/11 - 03:03 pm
Oculus Innovative Sciences
research
Oculus Innovative Sciences Reports Record First Quarter Financial Results
Thu, 08/4/11 - 11:41 pm
Oculus Innovative Sciences
earnings
AmDerma Pharmaceuticals Exercises Option to License Rights to Oculus Innovative Sciences Microcyn(R)-Based Acne Drug Candidate
Tue, 06/28/11 - 11:23 pm
AmDerma
liscense
Oculus Innovative Sciences
Drug
Oculus Innovative Sciences Launches Microcyn®-Compatible XuSorb™ Foam with Waterproof Cover Wound Dressing
Wed, 11/10/10 - 08:24 am
Oculus Innovative Sciences
wound care
Microcyn
XuSorb

Pages